Майборте - analogs
Components: Bortezomib |
|||||||||
Pharmgroups: Other antitumor agents || Antitumor drugs other |
|||||||||
| Prices in pharmacies: — Instructions Майборте | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Paracetamol ✘ (incl) Apixaban ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘ✘Analogues of the drug with completely identical active ingredients |
Prices in pharmacies |
| ≈100% | neutral BoramilanFS | 35-453.9€ |
| ≈100% | neutral Boramilan | 91.7€ |
| ≈100% | neutral Velcade | 140-149.4€ |
| ≈100% | neutral Bortezol | — |
| ≈100% | neutral Bortezomib | — |
| ≈100% | neutral Verozomib | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 40% 2264.6€ Adcetris neutral [Brentuximab Vedotin]
- 40% 2767.6-2790€ Zolinza neutral [Vorinostat]
- 37% — Lenalidomide neutral [Lenalidomide]
- 37% — Ленанжио neutral [Lenalidomide]
- 35% — Метибластан neutral [Lenalidomide]
- 34% — Lenalidomide-TL neutral [Lenalidomide]
- 33% 1328€ Revlimid neutral [Lenalidomide]
- 32% 788.9€ Kyprolis neutral [Carfilzomib]
- 31% — Ковада Negative 🔍 [Bendamustine]
- 31% — ГРАСТИГЕН Negative 🔍 [Bendamustine]
- 31% — Бендамустин Канон Negative 🔍 [Bendamustine]
- 31% — Меркудиес Negative 🔍 [Bendamustine]
- 31% — РОЗУСТИН Negative 🔍 [Bendamustine]
- 31% — Бендамустин-промомед Negative 🔍 [Bendamustine]
- 31% — Бендамустина гидрохлорид моногидрат Negative 🔍 [Bendamustine]
- 30% — Неларабин Negative 🔍 [Nelarabine]
- 30% 124-174.5€ Asparaginase medac Negative 🔍 [Asparaginase]
- 30% 45.1€ Vero-Asparaginase Negative 🔍 [Asparaginase]
- 30% 630€ Atriance Negative 🔍 [Nelarabine]
- 30% — Asparaginase Negative 🔍 [Asparaginase]
- 30% — L-asparaginase for injections Negative 🔍 [Asparaginase]
- 29% — Иматанго neutral [Pomalidomide]
- 29% — L-Asparaginase Negative 🔍 [Asparaginase]
- 29% — Pomalidomide-TL neutral [Pomalidomide]
- 29% 6352.5-6726.4€ Imnovid neutral [Pomalidomide]
- 28% — Фаридак neutral [Panobinostat]
- 25% 45-106€ Рибомустин Negative 🔍 [Bendamustine]
- 25% — Miltex neutral [Miltefosine]
- 25% 2964.5€ Пикрэй neutral [Alpelisib]
- 24% — Леналидомид-Тева neutral [Lenalidomide]
- 24% — Lenalidomide-nativ neutral [Lenalidomide]
- 24% — Lenalidomide-KRKA neutral [Lenalidomide]
- 24% — Мулмилида neutral [Lenalidomide]
- 24% — Ландотекс neutral [Lenalidomide]
- 24% — Миеланикс neutral [Lenalidomide]
- 24% — Леналидомид (форма-Н1) neutral [Lenalidomide]
- 24% — РУПСУЛИМИД neutral [Lenalidomide]
- 24% — Леналидомид-промомед neutral [Lenalidomide]
- 23% — Калквенс neutral [Akalabrutinib]
- 23% 927.6€ Oncaspar Negative 🔍 [Pegaspargase and more 1Asparaginase]
- 21% — Factor tumor necrosis-thymosine alpha-1 recombinant neutral [Tumor necrosis factor-thymosine alpha-1 recombinant]
- 21% — Hexalen Dangerous 🔍 [Altretamine]
- 21% 100-300€ Ацеллбия Negative 🔍 [Rituximab]
- 21% 15-21€ Цервикон -ДИМ neutral [Diindolylmethane]
- 20% — Иксазомиба цитрат neutral [Ixazomib]
- 20% — Oncofage neutral [Proteine]
- 20% — Помалидомид neutral [Pomalidomide]
- 20% 992.7€ Talcenna neutral [Talazoparib]
- 19% 73.4€ Venclexta neutral [Venetoclax]
- 18% — Metvix neutral [Methylaminolevulinate]
Learn more about the selection of analogues
- The drug has «Майборте» 14 full analogs, the cheapest - BoramilanFS (35-453.9€); 51 analog by action, the most similar - Adcetris (2264.6€).
- Medical online service has selected the best substitutes for Майборте based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Майборте to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.